Tamar Ben-Yedidia
Directeur Technique/Scientifique/R&D chez SCINAI IMMUNOTHERAPEUTICS LTD.
Profil
Tamar Ben-Yedidia is currently the Chief Science Officer at Scinai Immunotherapeutics Ltd.
since 2004.
Prior to this, she worked as a Lab Manager at Biotechnology General (Israel) Ltd.
from 1991 to 1994.
Dr. Ben-Yedidia received her undergraduate degree from Tel-Aviv University and her doctorate degree from Weizmann Institute of Science in 2000.
Postes actifs de Tamar Ben-Yedidia
| Sociétés | Poste | Début |
|---|---|---|
| SCINAI IMMUNOTHERAPEUTICS LTD. | Directeur Technique/Scientifique/R&D | 01/01/2004 |
Anciens postes connus de Tamar Ben-Yedidia
| Sociétés | Poste | Fin |
|---|---|---|
Biotechnology General (Israel) Ltd.
 Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel | Corporate Officer/Principal | 01/01/1994 |
Formation de Tamar Ben-Yedidia
| Weizmann Institute of Science | Doctorate Degree |
| Tel-Aviv University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SCINAI IMMUNOTHERAPEUTICS LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Biotechnology General (Israel) Ltd.
Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel | Health Technology |
